1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ipilimumab versus placebo after complete resection of stage III melanoma: Long-term follow-up results the EORTC 18071 double-blind phase 3 randomized trial
    Meeting Abstract

    Eggermont, A. M. M.; Chiarion-Sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC)
    Meeting Abstract

    Eastham, J. A.; Heller, G.; Halabi, S.; Monk, P.; Clinton, S. K.; Szmulewitz, R. Z.; Coleman, J.; Gleave, M.; Evans, C. P.; Hillman, D. W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Consistent efficacy of nivolumab plus ipilimumab across number of International Metastatic Database Consortium (IMDC) risk factors in CheckMate 214
    Meeting Abstract

    Escudier, B.; Motzer, R. J.; Tannir, N. M.; Porta, C.; Tomita, Y.; Mekan, S. F.; McHenry, M. B.; Rini, B. I.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of men with prostate cancer managed with active surveillance and tested with clinical cell-cycle risk score
    Meeting Abstract

    Ehdaie, B.; Kaul, S.; Wojno, K.; Evans, B.; Bernhisel, R.; Meek, S.; D'Anna, R.; Ferguson, J.; Glaser, J.; Morgan, T. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of LOXO-292, a highly selective RET inhibitor, in pediatric patients with RET-altered cancers
    Meeting Abstract

    DuBois, S. G.; Albert, C. M.; Mascarenhas, L.; Laetsch, T. W.; van Tilburg, C. M.; Potter, S. L.; Turpin, B.; Bender, J. L. G.; Spunt, S. L.; Hladun, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • NRG1 fusion-positive lung cancers: Clinicopathologic profile and treatment outcomes from a global multicenter registry
    Meeting Abstract

    Duruisseaux, M.; Liu, S. V.; Han, J. Y.; Gounant, V.; Shih, J. Y.; Schram, A. M.; Schrock, A. B.; Ali, S. M.; Magne, F.; Monnet, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Detection of subthreshold microsatellite instability in breast cancer: An ongoing investigation
    Meeting Abstract

    Drago, J. Z.; Latham, A.; Modi, S.; Razavi, P.; Stadler, Z. K.; Robson, M. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors
    Meeting Abstract

    Drilon, A. E.; DuBois, S. G.; Farago, A. F.; Geoerger, B.; Grilley-Olson, J. E.; Hong, D. S.; Sohal, D.; van Tilburg, C. M.; Ziegler, D. S.; Ku, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save